Mercury Laboratories Limited
MERCURYLAB.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$924M
Close$
$43.11
94.3% downside
Current Fair Value
94.3% downsideOvervalued by 94.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $924.00 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $3.50 (0.45%) |
| Earnings per Share | $40.28 |
| Beta | 0.4 |
| Outstanding Shares | 1,200,806 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 22.2 |
|---|---|
| PEG | -32.07 |
| Price to Sales | 1.24 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Mercury Laboratories Limited
510 employees
CEO: Rajendra Ramanlal Shah Established in 1962, Mercury Laboratories Ltd. is an Indian pharmaceutical company headquartered in Vadodara. The firm specializes in the manufacturing and distribution of medicinal products, serving a broad spectrum of medical fields su...